Skip to content

Warfarin

Athrombin, Coumadin, Panwarfin (warfarin) is a small molecule pharmaceutical. Warfarin was first approved as Athrombin on 1982-01-01. It is used to treat atrial fibrillation, postoperative complications, pulmonary embolism, stroke, and thromboembolism amongst others in the USA. The pharmaceutical is active against vitamin K epoxide reductase complex subunit 1. In addition, it is known to target Uncharacterized protein.
Trade Name Athrombin, Coumadin, Panwarfin
Common Name Warfarin
Indication atrial fibrillation, postoperative complications, pulmonary embolism, stroke, thromboembolism, thrombophlebitis
Drug Class Warfarin analogs
Warfarin
Get full access now